INDEMNIFICATION AGREEMENTIndemnification Agreement • November 4th, 2019 • Qilian International Holding Group LTD • Pharmaceutical preparations • New York
This Indemnification Agreement (this “Agreement”) is entered into as of by and between Qilian International Holding Group Limited, a Cayman Islands company (the “Company”), and the undersigned, a director and/or an officer of the Company (“Indemnitee”), as applicable.
QILIAN INTERNATIONAL HOLDING GROUP LIMITED UNDERWRITING AGREEMENTUnderwriting Agreement • December 23rd, 2020 • Qilian International Holding Group LTD • Pharmaceutical preparations • New York
EMPLOYMENT AGREEMENTEmployment Agreement • August 21st, 2020 • Qilian International Holding Group LTD • Pharmaceutical preparations
This EMPLOYMENT AGREEMENT (the “Agreement”), is entered into as of June 15, 2020 (the “Effective Date”), by and between Qilian International Holding Group Limited, incorporated under the laws of the Cayman Islands (the “Company”), and Haiping Shi, an individual (the “Chief Financial Officer (CFO)”). Except with respect to the direct employment of the CFO by the Company, the term “Company” as used herein with respect to all obligations of the CFO hereunder shall be deemed to include the Company and all of its subsidiaries and affiliated entities (collectively, the “Group”).
EMPLOYMENT AGREEMENTEmployment Agreement • November 4th, 2019 • Qilian International Holding Group LTD • Pharmaceutical preparations
This EMPLOYMENT AGREEMENT (the “Agreement”), is entered into as of June 6, 2019 (the “Effective Date”), by and between Qilian International Holding Group Limited, incorporated under the laws of the Cayman Islands (the “Company”), and Zhanchang Xin, an individual (the “Chief Technology Officer (CEO)”). Except with respect to the direct employment of the CEO by the Company, the term “Company” as used herein with respect to all obligations of the CEO hereunder shall be deemed to include the Company and all of its subsidiaries and affiliated entities (collectively, the “Group”).
Agricultural Bank of China Co., Ltd Working Capital Loan Contract No.:62010120200000188Qilian International Holding Group LTD • April 8th, 2020 • Pharmaceutical preparations
According to the applicable Chinese laws and regulations, both parties hereby enter into this contract through consultations.
EQUITY PLEDGE AGREEMENT ON GANSU QILIANSHAN PHARMACEUTICAL CO., LTD. AMONG [Shareholder’s Name] AND CHENGDU QILIAN TRADING CO., LTD. May 20, 2019 EQUITY PLEDGE AGREEMENTEquity Pledge Agreement • November 4th, 2019 • Qilian International Holding Group LTD • Pharmaceutical preparations
This EQUITY PLEDGE AGREEMENT (hereinafter, this "AGREEMENT") is entered into as of May 20, 2019 (“SIGNING DATE”) in Jiuquan City, the People’s Republic of China (“CHINA” or “PRC”) by and among the following Parties:
SHAREHOLDERS’ VOTING RIGHTS PROXY AGREEMENT ON GANSU QILIANSHAN PHARMACEUTICAL CO., LTD. AMONG [Shareholder’s Name] AND CHENGDU QILIAN TRADING CO., LTD. [Date] SHAREHOLDERS’ VOTING RIGHTS PROXY AGREEMENTShareholders’ Voting Rights Proxy Agreement • November 4th, 2019 • Qilian International Holding Group LTD • Pharmaceutical preparations
This SHAREHOLDERS’ VOTING RIGHTS PROXY AGREEMENT (this “AGREEMENT”) is entered into as of [Date] (“SIGNING DATE”) in [City], the People’s Republic of China (“CHINA” or “PRC”) by and among the following Parties:
CALL OPTION AGREEMENT ON GANSU QILIANSHAN PHARMACEUTICAL CO., LTD. AMONG [Shareholder’s Name] AND CHENGDU QILIAN TRADING CO., LTD. [Date]Call Option Agreement • November 4th, 2019 • Qilian International Holding Group LTD • Pharmaceutical preparations
This CALL OPTION AGREEMENT (this “AGREEMENT”) is entered into as of 【 , 2019】(“SIGNING DATE”) in Jiuquan City, the People’s Republic of China (“CHINA” or “PRC”) by and among the following Parties:
THE AMENDED EXCLUSIVE SERVICE AGREEMENT AMONG CHENGDU QILIAN TRADING CO., LTD AND GANSU QILIANSHAN PHARMECEUTICAL CO., LTD. August 27, 2019 THE AMENDED EXCLUSIVE SERVICE AGREEMENTAmended Exclusive Service Agreement • November 4th, 2019 • Qilian International Holding Group LTD • Pharmaceutical preparations
This AMENDED EXCLUSIVE SERVICE AGREEMENT (this “AGREEMENT”) is entered into as of August 27, 2019(“SIGNING DATE”) in Jiuquan City, the People’s Republic of China (“CHINA” or “PRC”) by and among the following Parties:
Investment AgreementInvestment Agreement • February 11th, 2022 • Qilian International Holding Group LTD • Pharmaceutical preparations
After friendly and equal consultation, both party a and party b to party b voluntarily in model. flood-control of high-tech investment construction pig by-products deep processing projects, according to the law of the People's Republic of China civil code, the land administration law of the People's Republic of China and other laws and regulations of the relevant regulations, in line with the principle of equality, voluntariness, honesty and credit to conclude the following contract.
EXCLUSIVE SERVICE SUPPLEMENTARY AGREEMENT AMENDMENTExclusive Service Supplementary Agreement • February 11th, 2022 • Qilian International Holding Group LTD • Pharmaceutical preparations
This EXCLUSIVE SERVICE SUPPLEMENTARY AGREEMENT AMENDMENT (this “ SUPPLEMENT AGREEMENT AMENDMENT”) is entered into as of February 25, 2021 (“SIGNING DATE”) in Jiuquan City, the People’s Republic of China (“CHINA” or “PRC”) by and among the following Parties:
THE EXCLUSIVE SERVICE AGREEMENT AMONG CHENGDU QILIAN TRADING CO., LTD AND GANSU QILIANSHAN PHARMECEUTICAL CO., LTD. May 20, 2019 THE EXCLUSIVE SERVICE AGREEMENTThe Exclusive Service Agreement • June 17th, 2019 • Qilian International Holding Group LTD • Pharmaceutical preparations
This EXCLUSIVE SERVICE AGREEMENT (this “AGREEMENT”) is entered into as of May 20, 2019 (“SIGNING DATE”) in Jiuquan City, the People’s Republic of China (“CHINA” or “PRC”) by and among the following Parties:
Loan contract Lanyin loan No. 102192020000015 of 2020 Bank of Lanzhou Limited by Share LtdQilian International Holding Group LTD • June 12th, 2020 • Pharmaceutical preparations
This Contract is hereby entered into by and between the Borrower and the Lender through equal and voluntary consultation as to the issue of lending to the Borrower.
THE EXCLUSIVE SERVICE AGREEMENT BETWEEN QILIAN SHAN INTERNATIONAL TRADE (HAINAN) CO., LTD AND GANSU QILIANSHAN PHARMECEUTICAL CO., LTD. December 1, 2022The Exclusive Service Agreement • December 7th, 2022 • Qilian International Holding Group LTD • Pharmaceutical preparations
This EXCLUSIVE SERVICE AGREEMENT (this “AGREEMENT”) is entered into as of December 1, 2022 (“SIGNING DATE”) in Jiuquan City, the People’s Republic of China (“CHINA” or “PRC”) by and among the following Parties:
QILIAN INTERNATIONAL HOLDING GROUP LIMITED (the “Issuer”) AND [TRUSTEE] (the “Trustee”) INDENTURE Dated as of [●], 2024 Senior Debt SecuritiesIndenture • April 10th, 2024 • Qilian International Holding Group LTD • Pharmaceutical preparations • New York
INDENTURE, dated as of [●], 2024, among QILIAN INTERNATIONAL HOLDING GROUP LIMITED, a Cayman Islands corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”).
Strain Reconstruction Framework Cooperation AgreementQilian International Holding Group LTD • September 9th, 2019 • Pharmaceutical preparations
On the principle of equality and mutual benefit, both parties have signed this agreement with the aim of transforming Streptomyces rimosus. and improving their production efficiency through mutation, and both parties abide by and fulfill their obligations.
contract Corresponding entrustment contract number:_________________________Qilian International Holding Group LTD • August 21st, 2020 • Pharmaceutical preparations
In accordance with the provisions of the Contract Law of the People's Republic of China and other laws and regulations, A and B, after friendly consultation and on the principle of equality and mutual benefit,
AGREEMENT TO TERMINATE THE VIE SERVICE AGREEMENTVie Service Agreement • December 7th, 2022 • Qilian International Holding Group LTD • Pharmaceutical preparations
This Termination Agreement is entered as of December 1, 2022 ("Effective Date") in Jiuquan City, the People’s Republic of China (“China” or “PRC”) by and between the following Parties:
